Capvaxive shows strong immune response in children at risk of pneumococcal disease
Written by
PharmaTimes
Published
0
comments
0
min
Merck presents phase 3 STRIDE-13 trial results at ESCMID conference in Lisbon Merck presents phase 3 STRIDE-13 trial results at ESCMID conference in Lisbon